AI Transforms Flavor R&D: Givaudan Accelerates Innovation with Stravito's Genie Platform
Givaudan leverages Stravito's AI platform, 'Genie', to streamline consumer research analysis, reducing insight generation time and accelerating flavor innovation for new product development.
AI-assisted coverage: produced by SF News' automated newsroom from the cited sources and checked by automated attribution gates. Editorial responsibility: Lee Smith, Group CEO. How we work →
Geneva, Switzerland — 17 September 2026
Givaudan, a leading flavour and fragrance company, is strategically deploying an artificial intelligence (AI) platform developed by Stravito to significantly enhance its flavour innovation process. The platform, internally dubbed 'Genie', functions as a centralised knowledge repository, converting fragmented consumer research and market intelligence into actionable insights. This initiative directly addresses a critical bottleneck where Givaudan's extensive data was dispersed across multiple platforms and systems, slowing down the response to client briefs, as noted by Basak Oker, Marketing and Consumer Sensory Insights Director for Europe at Givaudan.
The integration of 'Genie' aims to accelerate the transition from consumer insight to flavour innovation decisions. Previously, Givaudan's experts spent considerable time aggregating and structuring information before analysis. The AI assistant now automates much of this data synthesis, allowing human experts to focus on interpreting findings, challenging evidence, and developing bespoke recommendations for formulations that meet specific consumer demands. This operational shift enables Givaudan to address client briefs with greater speed, leveraging years of proprietary expertise more efficiently.
Stravito's CEO, Thor Olof Philogène, highlights the platform's 'Glass Box AI' principles, which differentiate it from generic AI solutions. 'Genie' provides synthesised, source-cited answers linked directly back to underlying research, ensuring transparency and traceability. This capability allows Givaudan's teams to verify the evidence supporting AI-generated insights, fostering trust and enabling critical human judgment. While AI streamlines data identification and synthesis, Givaudan maintains that the creative leap from consumer insight to a successful product launch, including sensory attributes like taste and smell, remains a distinctly human endeavour.
What this means for United Kingdom
UK supplement brand owners and manufacturers must anticipate accelerated product development cycles from ingredient suppliers like Givaudan, translating into shorter reformulation windows and increased pressure for agile product launches. Leveraging AI for internal market intelligence, mirroring Givaudan's approach, could reduce new product lead times by 20-30%, a critical factor in a competitive market. Brand owners should assess their own data management strategies to prevent being outpaced by suppliers' AI-driven efficiencies. Compliance teams should note that rapid innovation cycles necessitate equally rapid regulatory assessments, requiring proactive engagement with MHRA guidance on novel ingredients and claims, especially for AI-derived formulations. Ingredient supply chain managers will need to adapt MOQs and forecasting to match this quicker turnaround, maintaining inventory without incurring excessive holding costs.
Brand owners increasingly rely on contract-manufacturing partners such as Supplement Factory to navigate these requirements.